Malaria is common in areas such as Africa, South America, and Southern Asia. This medicine is not effective against all strains of malaria. Is plaquenil an antibiotic How does plaquenil affect lichen planus Plaquenil uses for granuloma annulare Hydroxychloroquine HCQ, sold under the brand name Plaquenil among others, is a medication used for the prevention and treatment of certain types of malaria. Specifically it is used for chloroquine -sensitive malaria. Other uses include treatment of rheumatoid arthritis, lupus, and porphyria cutanea tarda. The lag time between oral absorption of hydroxychloroquine sulfate 200 mg and its measurement in the blood is typically 0–0.85 h mean 0.43 h 37, and both hydroxychloroquine and chloroquine. Hydroxychloroquine is an investigational drug that is categorized as an immune modulator. 2 Immune modulators also called immunomodulators are substances that help to activate, boost, or restore normal immune function. Taking hydroxychloroquine long-term or at high doses may cause irreversible damage to the retina of your eye. Hydroxychloroquine is also an antirheumatic medicine and is used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus. Hydroxychloroquine sulfate pharmacological class Hydroxychloroquine Sulfate Drug Information, Professional, Mechanisms of action of hydroxychloroquine and chloroquine. Prilosec and plaquenil interactionsSjogrens plaquenil availablePlaquenil withdrawal symptomsKeyhole chloroquinePlaquenil and atenolol Sep 01, 2019 Hydroxychloroquine sulfate tablets are not effective against chloroquine or hydroxychloroquine-resistant strains of Plasmodium species see CLINICAL PHARMACOLOGY – Microbiology. Hydroxychloroquine sulfate tablets are not recommended for the treatment of malaria acquired in geographic areas where chloroquine resistance occurs or when the. Hydroxychloroquine Tablets - FDA prescribing information.. Hydroxychloroquine Clinical Trials, Side Effects AIDSinfo. Hydroxychloroquine Advanced Patient Information -. Irreversible retinal damage observed in some patients who had received hydroxychloroquine sulfate; significant risk factors for retinal damage include daily doses of hydroxychloroquine sulfate greater than 6.5 mg/kg 5 mg/kg base of actual body weight, durations of use greater than five years, subnormal glomerular filtration, use of some concomitant drug products such as tamoxifen citrate and concurrent macular disease Hydroxychloroquine sulfate tablets, USP are white, to off-white, capsule-shaped tablets, debossed "HCQS" on one side and plain on the reverse side and are available in bottles of 10, 100, 5. Each tablet contains 200 mg hydroxychloroquine sulfate, USP equivalent to 155 mg base. Adults 400 mg of sulfate 310 mg base P. O. weekly on exactly the same day each week. Begin 2 weeks before entering the endemic area and continue for 8 weeks after leaving. Infants and children 5 mg, calculated as base per kilogram of body weight shouldn’t exceed the adult dose regardless of weight on exactly the same day each week.